• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病进展影响高密度脂蛋白对脂蛋白脂肪酶(LPL)介导的极低密度脂蛋白脂解效率的作用。

Progression of Chronic Kidney Disease Affects HDL Impact on Lipoprotein Lipase (LPL)-Mediated VLDL Lipolysis Efficiency.

作者信息

Ćwiklińska Agnieska, Cackowska Monika, Wieczorek Ewa, Król Ewa, Kowalski Robert, Kuchta Agnieszka, Kortas-Stempak Barbara, Gliwińska Anna, Dąbkowski Kamil, Zielińska Justyna, Dębska-Ślizień Alicja, Jankowski Maciej

机构信息

Department of Clinical Chemistry, Medical University of Gdańsk, Gdańsk, Poland,

Department of Nephrology, Transplantology and Internal Diseases, Medical University of Gdańsk, Gdańsk, Poland.

出版信息

Kidney Blood Press Res. 2018;43(3):970-978. doi: 10.1159/000490686. Epub 2018 Jun 15.

DOI:10.1159/000490686
PMID:29913451
Abstract

BACKGROUND/AIMS: Hypertriglyceridaemia (HTG) and reduction and dysfunction of high density lipoprotein (HDL) are common lipid disturbances in chronic kidney disease (CKD). HTG in CKD is caused mainly by the decreased efficiency of lipoprotein lipase (LPL)-mediated very low density lipoprotein triglyceride (VLDL-TG) lipolysis. It has not been clarified whether HDL dysfunction in CKD contributes directly to HTG development; thus, the aim of this study was to assess the impact of CKD progression on the ability of HDL to enhance LPL-mediated VLDL-TG lipolysis efficiency.

METHODS

VLDL was isolated from non-dialysis patients in CKD stages 3 and 4 and from non-CKD patients. The VLDL was incubated with LPL at the constant LPL:VLDL-TG ratio, in the absence or presence of HDL. After incubation, the VLDL was separated and the percentage (%) of hydrolyzed TG was calculated.

RESULTS

HDL presence increased the lipolysis efficiency of VLDL isolated from CKD and non-CKD patients, for the VLDL-TG> 50 mg/dl. Its effect was dependent on the VLDL-TG and HDL-cholesterol concentrations in the reaction mixtures: the higher the concentrations of VLDL-TG and HDL-cholesterol, the greater the effect. The positive impact of HDL on VLDL lipolysis was modified by CKD progression: the percentage of lipolyzed VLDL-TG in the presence of HDL decreased with a reduction in eGFR (r=0.43, p=0.009), and for patients with stage 4 CKD, no positive impact of HDL on lipolysis was observed. The percentage of lipolyzed TG correlated negatively with apoE and apoCs content in VLDL, and positively with HDL-apoCII, as well as with VLDL and HDL apoCII/ apoCIII ratios. The progression of CKD was associated with unfavourable changes in VLDL and HDL composition; apoE and apoCs levels increased in VLDL with a decrease in eGFR whereas the HDL-cholesterol level decreased.

CONCLUSION

The progression of CKD affects lipoprotein composition and properties, and modulates the positive impact of HDL on VLDL lipolysis efficiency. In CKD patients, HDL deficiency and dysfunction can directly affect hypertriglyceridaemia development.

摘要

背景/目的:高甘油三酯血症(HTG)以及高密度脂蛋白(HDL)水平降低和功能障碍是慢性肾脏病(CKD)常见的脂质紊乱情况。CKD中的HTG主要由脂蛋白脂肪酶(LPL)介导的极低密度脂蛋白甘油三酯(VLDL-TG)脂解效率降低所致。目前尚不清楚CKD中的HDL功能障碍是否直接导致HTG的发生;因此,本研究的目的是评估CKD进展对HDL增强LPL介导的VLDL-TG脂解效率能力的影响。

方法

从CKD 3期和4期的非透析患者以及非CKD患者中分离VLDL。将VLDL在LPL与VLDL-TG比例恒定的情况下,于不存在或存在HDL的条件下与LPL一起孵育。孵育后,分离VLDL并计算水解甘油三酯的百分比(%)。

结果

对于VLDL-TG>50mg/dl的情况,HDL的存在提高了从CKD和非CKD患者中分离出的VLDL的脂解效率。其作用取决于反应混合物中VLDL-TG和HDL胆固醇的浓度:VLDL-TG和HDL胆固醇的浓度越高,作用越大。HDL对VLDL脂解的积极影响因CKD进展而改变:在存在HDL的情况下,脂解的VLDL-TG百分比随着估算肾小球滤过率(eGFR)的降低而降低(r=0.43,p=0.009),并且对于4期CKD患者,未观察到HDL对脂解有积极影响。脂解甘油三酯的百分比与VLDL中的载脂蛋白E(apoE)和载脂蛋白C(apoCs)含量呈负相关,与HDL-载脂蛋白CII(HDL-apoCII)呈正相关,也与VLDL和HDL的apoCII/apoCIII比值呈正相关。CKD的进展与VLDL和HDL组成的不利变化相关;随着eGFR降低,VLDL中的apoE和apoCs水平升高,而HDL胆固醇水平降低。

结论

CKD的进展会影响脂蛋白的组成和性质,并调节HDL对VLDL脂解效率的积极影响。在CKD患者中,HDL缺乏和功能障碍可直接影响高甘油三酯血症的发生。

相似文献

1
Progression of Chronic Kidney Disease Affects HDL Impact on Lipoprotein Lipase (LPL)-Mediated VLDL Lipolysis Efficiency.慢性肾脏病进展影响高密度脂蛋白对脂蛋白脂肪酶(LPL)介导的极低密度脂蛋白脂解效率的作用。
Kidney Blood Press Res. 2018;43(3):970-978. doi: 10.1159/000490686. Epub 2018 Jun 15.
2
Impact of phosphatidylcholine liposomes on the compositional changes of VLDL during lipoprotein lipase (LPL)-mediated lipolysis.磷脂酰胆碱脂质体对脂蛋白脂肪酶(LPL)介导的脂解过程中极低密度脂蛋白(VLDL)组成变化的影响。
Chem Phys Lipids. 2016 Feb;195:63-70. doi: 10.1016/j.chemphyslip.2015.12.007. Epub 2016 Jan 3.
3
Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.脂蛋白脂肪酶和肝脂肪酶对极低密度脂蛋白(VLDL)脂解过程中VLDL和高密度脂蛋白(HDL)转化的影响。
Atherosclerosis. 1995 Dec;118(2):193-212. doi: 10.1016/0021-9150(95)05606-8.
4
Lipolytic remnants of human VLDL produced in vitro. Effect of HDL levels in the lipolysis mixtures on the apoCs to apoE ratio and metabolic properties of VLDL core remnants.体外产生的人极低密度脂蛋白(VLDL)的脂解残余物。脂解混合物中高密度脂蛋白(HDL)水平对载脂蛋白C(apoC)与载脂蛋白E(apoE)比率以及VLDL核心残余物代谢特性的影响。
J Lipid Res. 2000 Feb;41(2):285-97.
5
Inhibition of lipoprotein lipase induced cholesterol ester accumulation in human hepatoma HepG2 cells.脂蛋白脂肪酶的抑制作用诱导人肝癌HepG2细胞中胆固醇酯的积累。
Atherosclerosis. 1996 Feb;120(1-2):101-14. doi: 10.1016/0021-9150(95)05690-4.
6
Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.高甘油三酯血症中极低密度脂蛋白和低密度脂蛋白与低密度脂蛋白受体结合的结构特性:载脂蛋白E的作用
Biochim Biophys Acta. 2000 Feb 24;1484(1):29-40. doi: 10.1016/s1388-1981(99)00197-3.
7
Catabolic defect of triglyceride is associated with abnormal very-low-density lipoprotein in experimental nephrosis.实验性肾病中甘油三酯的分解代谢缺陷与异常极低密度脂蛋白有关。
Metabolism. 1990 Jan;39(1):101-7. doi: 10.1016/0026-0495(90)90155-6.
8
The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding.非诺贝特治疗高甘油三酯血症的降血脂作用是通过脂蛋白脂肪酶的上调介导的:对极低密度脂蛋白底物与脂解的亲和力或低密度脂蛋白受体结合无影响。
Atherosclerosis. 2000 Dec;153(2):363-71. doi: 10.1016/s0021-9150(00)00409-3.
9
Lipolyzed hypertriglyceridemic serum and triglyceride-rich lipoprotein cause lipid accumulation in and are cytotoxic to cultured human endothelial cells. High density lipoproteins inhibit this cytotoxicity.脂解的高甘油三酯血症血清和富含甘油三酯的脂蛋白会导致培养的人内皮细胞内脂质蓄积并对其具有细胞毒性。高密度脂蛋白可抑制这种细胞毒性。
Thromb Res. 1990 May 1;58(3):251-64. doi: 10.1016/0049-3848(90)90095-t.
10
Decreased Efficiency of Very-Low-Density Lipoprotein Lipolysis Is Linked to Both Hypertriglyceridemia and Hypercholesterolemia, but It Can Be Counteracted by High-Density Lipoprotein.极低密度脂蛋白脂解效率降低与高甘油三酯血症和高胆固醇血症有关,但高密度脂蛋白可以对抗这种作用。
Nutrients. 2021 Apr 8;13(4):1224. doi: 10.3390/nu13041224.

引用本文的文献

1
The Effect of Increased Plant Protein Intake on the Lipid Profile of Chronic Kidney Disease Patients: A Meta-Analysis of Controlled Clinical Trials.增加植物蛋白摄入量对慢性肾脏病患者血脂谱的影响:一项对照临床试验的荟萃分析
Nutrients. 2025 Apr 23;17(9):1408. doi: 10.3390/nu17091408.
2
High-Density Lipoprotein in Patients with Diabetic Kidney Disease: Friend or Foe?糖尿病肾病患者中的高密度脂蛋白:是友还是敌?
Int J Mol Sci. 2025 Feb 16;26(4):1683. doi: 10.3390/ijms26041683.
3
ANGPTL3 (Angiopoietin-Like 3) Preferentially Resides on High-Density Lipoprotein in the Human Circulation, Affecting Its Activity.
ANGPTL3(血管生成素样蛋白 3)在人体循环中优先存在于高密度脂蛋白上,影响其活性。
J Am Heart Assoc. 2023 Nov 7;12(21):e030476. doi: 10.1161/JAHA.123.030476. Epub 2023 Oct 27.
4
Transcriptional sequencing analysis reveals the potential use of deer antler for "tonifying the kidney and strengthening bone".转录组测序分析揭示了鹿茸“补肾壮骨”的潜在用途。
J Orthop Surg Res. 2022 Sep 14;17(1):419. doi: 10.1186/s13018-022-03308-w.
5
The differences of serum lipid profiles between primary aldosteronism and essential hypertension: a meta-analysis and systematic review.原发性醛固酮增多症与原发性高血压患者血脂谱的差异:一项荟萃分析和系统评价。
BMC Endocr Disord. 2022 Aug 31;22(1):217. doi: 10.1186/s12902-022-01135-y.
6
Changes in the size and electrophoretic mobility of HDL subpopulation particles in chronic kidney disease.慢性肾脏病患者中 HDL 亚群颗粒的大小和电泳迁移率的变化。
J Nephrol. 2023 Jan;36(1):115-124. doi: 10.1007/s40620-022-01412-y. Epub 2022 Aug 9.
7
Emerging Evidence of Pathological Roles of Very-Low-Density Lipoprotein (VLDL).越来越多的证据表明极低密度脂蛋白(VLDL)具有病理性作用。
Int J Mol Sci. 2022 Apr 13;23(8):4300. doi: 10.3390/ijms23084300.
8
The Differential Effects of HDL Subpopulations on Lipoprotein Lipase (LPL)-Mediated VLDL Catabolism.高密度脂蛋白亚群对脂蛋白脂肪酶(LPL)介导的极低密度脂蛋白分解代谢的差异影响。
Biomedicines. 2021 Dec 5;9(12):1839. doi: 10.3390/biomedicines9121839.
9
Development of a Longitudinal Diagnosis and Prognosis in Patients with Chronic Kidney Disease: Intelligent Clinical Decision-Making Scheme.慢性肾脏病患者纵向诊断和预后的开发:智能临床决策方案。
Int J Environ Res Public Health. 2021 Dec 4;18(23):12807. doi: 10.3390/ijerph182312807.
10
Subpopulations of High-Density Lipoprotein: Friends or Foes in Cardiovascular Disease Risk in Chronic Kidney Disease?高密度脂蛋白亚群:慢性肾脏病心血管疾病风险中的友或敌?
Biomedicines. 2021 May 16;9(5):554. doi: 10.3390/biomedicines9050554.